MOR vs. CNXC
MOR (MorphoSys AG) and CNXC (Concentrix Corporation) are both stocks. MOR operates in Biotechnology (Healthcare), while CNXC operates in Information Technology Services (Technology). Over the past 5 years, MOR returned -1.86%/yr vs -26.78%/yr for CNXC. At a 0.09 correlation, their price movements are largely independent.
Performance
MOR vs. CNXC - Performance Comparison
Loading charts...
Returns By Period
MOR
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- 42.30%
- 5Y*
- -1.86%
- 10Y*
- —
CNXC
- 1D
- 3.22%
- 1M
- 19.79%
- YTD
- -29.70%
- 6M
- -20.91%
- 1Y
- -45.85%
- 3Y*
- -29.28%
- 5Y*
- -26.78%
- 10Y*
- —
MOR vs. CNXC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
MOR MorphoSys AG | 0.00% | 0.00% | 91.52% | 176.54% | -62.00% | -66.76% | 5.59% |
CNXC Concentrix Corporation | -29.70% | -1.39% | -55.03% | -25.36% | -24.91% | 81.22% | 23.37% |
Correlation
The correlation between MOR and CNXC is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (3Y) Calculated over the trailing 3-year period | -0.00 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Nov 25, 2020 | 0.09 |
Fundamentals
MOR:
$203.58M
CNXC:
$9.95B
MOR:
$162.36M
CNXC:
$3.27B
MOR:
-$348.58M
CNXC:
-$944.68M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MOR vs. CNXC — Risk / Return Rank
MOR
CNXC
MOR vs. CNXC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MorphoSys AG (MOR) and Concentrix Corporation (CNXC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| MOR | CNXC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | -0.75 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.03 | -0.56 | +0.52 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.08 | -0.32 | +0.24 |
Drawdowns
MOR vs. CNXC - Drawdown Comparison
The maximum MOR drawdown since its inception was -91.41%, roughly equal to the maximum CNXC drawdown of -87.86%. Use the drawdown chart below to compare losses from any high point for MOR and CNXC.
Loading charts...
Drawdown Indicators
| MOR | CNXC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.41% | -87.86% | -3.55% |
Max Drawdown (1Y)Largest decline over 1 year | 0.00% | -61.71% | +61.71% |
Max Drawdown (3Y)Largest decline over 3 years | -47.09% | -76.50% | +29.41% |
Max Drawdown (5Y)Largest decline over 5 years | -85.17% | -87.86% | +2.69% |
Current DrawdownCurrent decline from peak | -49.25% | -84.85% | +35.60% |
Average DrawdownAverage peak-to-trough decline | -48.69% | -47.60% | -1.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.00% | 37.01% | -37.01% |
Volatility
MOR vs. CNXC - Volatility Comparison
The current volatility for MorphoSys AG (MOR) is 0.00%, while Concentrix Corporation (CNXC) has a volatility of 16.05%. This indicates that MOR experiences smaller price fluctuations and is considered to be less risky than CNXC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MOR | CNXC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 16.05% | -16.05% |
Volatility (6M)Calculated over the trailing 6-month period | 0.00% | 51.93% | -51.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 61.30% | -61.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 55.93% | 48.26% | +7.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 51.95% | 49.80% | +2.15% |
Dividends
MOR vs. CNXC - Dividend Comparison
MOR has not paid dividends to shareholders, while CNXC's dividend yield for the trailing twelve months is around 4.94%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
CNXC Concentrix Corporation | 4.94% | 3.27% | 2.87% | 1.15% | 0.77% | 0.14% |
MOR MorphoSys AG | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MOR vs. CNXC - Financials Comparison
This section allows you to compare key financial metrics between MorphoSys AG and Concentrix Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MOR and CNXC have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CNXC has higher volatility (16.05%) compared to MOR (0.00%). In terms of maximum drawdown, MOR dropped -91.41% vs CNXC's -87.86%.
Find the right allocation for MOR and CNXC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer